Similar articles

• HLA-A9 and survival in acute lymphocytic leukemia and myelocytic leukemia.

  Cohen E, Singal DP, Khurana U, Gregory SG, Cox C, Sinks L, Henderson E, Fitzpatrick JE, Higby D. Cohen E, et al. Prog Clin Biol Res. 1977;16:65-70. Prog Clin Biol Res. 1977. PMID: 269457 No abstract available.
• HLA associations with acute myelogenous leukemia.

  Parrish EJ, Heise ER, Cooper MR. Parrish EJ, et al. Prog Clin Biol Res. 1977;16:81-9. Prog Clin Biol Res. 1977. PMID: 269459 No abstract available.
• HLA and cancer.

  Hors J, Andrieu JM, Gony J. Hors J, et al. Transplant Proc. 1984 Apr;16(2):455-7. Transplant Proc. 1984. PMID: 6586006 No abstract available.
• The HLA system in acute leukaemia and Hodgkin's disease.

  Harris R, Lawler SD, Oliver RT. Harris R, et al. Br Med Bull. 1978 Sep;34(3):301-4. doi: 10.1093/oxfordjournals.bmb.a071516. Br Med Bull. 1978. PMID: 363226 Review. No abstract available.
• Ia antigens: definition of the HLA-DRw specificities.

  Bodmer JG. Bodmer JG. Br Med Bull. 1978 Sep;34(3):233-40. doi: 10.1093/oxfordjournals.bmb.a071503. Br Med Bull. 1978. PMID: 82460 Review. No abstract available.